Clinical trial Recruiting at 1 site Interventional Ages 20 to 40 Women only

Fecal microbiota transplantation for overweight women with PMOS undergoing embryo transfer

Official title: Fecal Microbiota Transplantation for the Treatment of Polyendocrine Metabolic Ovarian Syndrome in Obese Women:A Phase Ⅰ/ⅡSingle-Arm Pilot Study and Planned Randomized Controlled Trial

Run by Shanghai Changzheng Hospital · NCT07746635 · Data updated 2026-11-12

We are testing if oral FMT capsules are safe and can improve pregnancy outcomes for overweight/obese women with PMOS undergoing frozen embryo transfer.

More PCOS (Polycystic Ovary Syndrome) trials

Quick facts

Study typeInterventional
Ages20 Years to 40 Years
SexWomen only
Enrollment411 (estimated)
SponsorShanghai Changzheng Hospital
Academic / other
Locations1 site (Shanghai, Shanghai Municipality)
StatusRecruiting
StartedApril 15, 2025
Main results expectedDecember 31, 2028
Study endsDecember 31, 2028
Registry record updatedNovember 10, 2026
Trial IDNCT07746635 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Women aged 20-40 with PMOS, BMI ≥ 24 kg/m2, scheduled for FET, and willing to participate.

Probably not a fit

Individuals outside the PMOS spectrum, with BMI below 24, or not undergoing FET may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This trial tests oral fecal microbiota transplantation (FMT) capsules in overweight or obese women with Polyendocrine Metabolic Ovarian Syndrome (PMOS) who are having a frozen-thawed embryo transfer. It consists of two stages: a small, open-label pilot to assess safety and preliminary effects on gut microbiota and pregnancy outcomes, followed by a larger randomized controlled trial to confirm efficacy against standard care or placebo. The study measures safety, metabolic and endocrine changes, and reproductive outcomes, with Phase 2 designed to validate mechanisms identified in Phase 1. The intervention uses freeze-dried oral FMT capsules and compares them to a control in a multicenter setting after initial single-center exploration.

Why it matters

Potential benefit: If successful, participants may experience improved reproductive outcomes and metabolic/endocrine health related to PMOS.

How similar studies have gone: This approach is exploratory; similar FMT strategies have shown potential in metabolic conditions but direct success in PMOS-related fertility is not yet established.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* 1\. Females aged 20 to 40 years old.
* 2\. Meeting the diagnostic criteria for Polyendocrine Metabolic Ovarian Syndrome (PMOS).
* 3\. Body Mass Index (BMI): \>24.0 kg/m²(covering overweight and obese patients according to Asian criteria, addressing the actual recruited cohort ranging from 24.0 kg/m² upwards).
* 4\. Scheduled to undergo Frozen-Thawed Embryo Transfer (FET) at the Reproductive Medicine Center.
* 5\. Voluntary participation with signed Informed Consent Form (ICF).

Exclusion Criteria:

* Age \< 20 or \> 40 years.
* Pregnancy or lactation.
* Other endocrine disorders (e.g., Cushing's syndrome, thyroid dysfunction); severe organ dysfunction or impaired intestinal mucosal barrier; use of antibiotics, probiotics, or prebiotics within 1 month.
* Use of ovulation-modifying or anti-androgen drugs within 3 months; severe psychiatric disorders.
* Concurrent participation in other clinical trials.

Where it's running

  • Center for Reproductive Medicine,Shanghai Changzheng Hospital
    Shanghai, Shanghai Municipality, China
    Recruiting

Study contacts

  • Principal investigator: Ningxia Sun, MD-PhD — Shanghai Changzheng Hospital
  • Study coordinator: Ningxia Sun, Chief
  • Email: suesunchzh@126.com
  • Phone: 13817975897

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.